Jefferies Financial Group’s Tarsus Pharmaceuticals TARS Stock Holding History

Jefferies Financial Group’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.48M	Hold	118,810	–	–	0.05%	300
2026 Q1	$8.33M	Hold	118,810	–	–	0.06%	233
2025 Q4	$9.73M	Buy	118,810 +5,741	+5%	+$429K	0.05%	326
2025 Q3	$6.72M	Sell	113,069 -49,927	-31%	-$2.46M	0.03%	298
2025 Q2	$6.6M	Buy	162,996 +84,188	+107%	+$3.79M	0.06%	234
2025 Q1	$4.05M	Sell	78,808 -341,950	-81%	-$16.9M	0.04%	355
2024 Q4	$23.3M	Hold	420,758	–	–	0.14%	109
2024 Q3	$13.8M	Hold	420,758	–	–	0.1%	127
2024 Q2	$11.4M	Buy	420,758 +150,000	+55%	+$5.04M	0.12%	134
2024 Q1	$9.84M	Sell	270,758 -110,000	-29%	-$3.23M	0.09%	173
2023 Q4	$7.71M	Buy	380,758 +50,000	+15%	+$835K	0.05%	282
2023 Q3	$5.88M	Sell	330,758 -25,000	-7%	-$442K	0.05%	298
2023 Q2	$6.43M	Sell	355,758 -90,000	-20%	-$1.43M	0.06%	295
2023 Q1	$5.6M	Hold	445,758	–	–	0.05%	331
2022 Q4	$6.53M	Buy	+445,758	New	+$7.38M	0.05%	323

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jefferies Financial Group's TARS Position: Q2 2026 in Review

Jefferies Financial Group held its Tarsus Pharmaceuticals (TARS) position steady in Q2 2026 at 118,810 shares worth $7.48M. The position accounts for 0.05% of the portfolio, ranked #300.

Jefferies Financial Group first reported a position in TARS in Q4 2022 and has held it in 15 quarters since. The position peaked at $23.3M in Q4 2024. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

Jefferies Financial Group held 118,810 shares of Tarsus Pharmaceuticals worth $7.48M as of Q2 2026.
Jefferies Financial Group left its Tarsus Pharmaceuticals share count unchanged in Q2 2026.
Tarsus Pharmaceuticals made up 0.05% of Jefferies Financial Group's portfolio in Q2 2026, its #300 holding.
Jefferies Financial Group first reported a position in Tarsus Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
Jefferies Financial Group's Tarsus Pharmaceuticals position peaked at $23.3M in Q4 2024.
257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.